# Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without Diabetes

> **NCT01492283** · — · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 48 (actual)

## Conditions studied

- Non Alcoholic Fatty Liver Disease
- Type 2 Diabetes
- Liver Cirrhosis

## Interventions

- **OTHER:** OGTT
- **OTHER:** IIGI

## Key facts

- **NCT ID:** NCT01492283
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-05
- **Final completion:** 2014-07
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2014-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01492283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01492283, "Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01492283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*